Skip to main content
Clinical Trials/IRCT20220603055066N1
IRCT20220603055066N1
Recruiting
N/A

Comparative evaluation of PRP (Platelet-Rich Plasma) with nutritional supplements in improvement of hair loss (telogen effluvium) in patients recovered from COVID-19 in Bam Pasteur hospital in 2022

Bam University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
telogen effluvium.
Sponsor
Bam University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Bam University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age 20 to 50 years
  • Covid 19 disease (positive by PCR test) 2 to 4 months before enrollment
  • Occurrence of persistent and significant hair loss after Covid 19 disease, which according to the diagnosis of a dermatologist has a pattern similar to telogen effluvium

Exclusion Criteria

  • People who are diagnosed as the other types of alopecia (except telogen effluvium)
  • Pregnant or lactating women
  • Patients who are being treated with drugs such as finasteride, spironolactone, minoxidil or OCP or who have recently stopped taking these drugs
  • Patients who have an underlying disease affecting hair loss
  • Lack of informed consent to enter the study

Outcomes

Primary Outcomes

Not specified

Similar Trials